Related Experiment Videos
Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase
1McGill Cancer Centre, McGill University, Montréal, Québec, Canada H3G 1Y6.
Abstract:
Antigen receptor-triggered T-cell activation is mediated by the sequential action of the Src and Syk/Zap-70 families of protein tyrosine kinases (PTKs). Previously, we reported that another PTK termed p50(csk) was a potent negative regulator of T-cell receptor (TCR) signaling because of its ability to inactivate Src-related kinases. This inhibitory effect required the catalytic activity of Csk, as well as its Src homology (SH)3 and SH2 domains. Subsequent studies uncovered that, via its SH3 domain, p50(csk) was associated with PEP, a proline-enriched protein tyrosine phosphatase (PTP) of unknown function expressed in hemopoietic cells. Herein, we have attempted to identify the role of the Csk-PEP complex in T lymphocytes. The results of our experiments showed that, like Csk, PEP was a strong repressor of TCR signaling. This property was dependent on the phosphatase activity of PEP, as well as on the sequence mediating its binding to p50(csk). Through reconstitution experiments in Cos-1 cells, evidence was obtained that Csk and PEP act synergistically to inhibit protein tyrosine phosphorylation by Src-related kinases, and that this effect requires their association. Finally, experiments with a substrate-trapping mutant of PEP suggested that PEP functions by dephosphorylating and inactivating the PTKs responsible for T-cell activation. In addition to giving novel insights into the mechanisms involved in the negative regulation of T-cell activation, these findings indicate that the association of an inhibitory PTK with a PTP constitutes a more efficient means of inhibiting signal transduction by Src family kinases in vivo.
Insights
The Csk-PEP complex, comprising a protein tyrosine kinase and phosphatase, acts synergistically to inhibit T-cell receptor signaling by dephosphorylating key kinases, offering a novel regulatory mechanism.
Area of Science:
- Immunology
- Molecular Biology
- Signal Transduction
Background:
- T-cell activation relies on sequential protein tyrosine kinase (PTK) activity.
- p50(csk) negatively regulates T-cell receptor (TCR) signaling by inactivating Src-related kinases.
- p50(csk) associates with proline-enriched protein tyrosine phosphatase (PEP) via its SH3 domain.
Purpose of the Study:
- To elucidate the role of the Csk-PEP complex in T lymphocytes.
- To understand the functional significance of the Csk-PEP association in TCR signaling.
Main Methods:
- Investigated PEP's role in TCR signaling in T lymphocytes.
- Utilized reconstitution experiments in Cos-1 cells to study Csk-PEP synergy.
- Employed a substrate-trapping mutant of PEP to determine its enzymatic function.
Main Results:
- PEP, like Csk, strongly represses TCR signaling, dependent on its phosphatase activity and Csk binding.
- Csk and PEP synergistically inhibit Src-related kinase-mediated phosphorylation, requiring their association.
- PEP dephosphorylates and inactivates PTKs crucial for T-cell activation.
Conclusions:
- The Csk-PEP complex provides a potent negative regulatory mechanism for T-cell activation.
- The association of an inhibitory PTK with a PTP enhances the inhibition of Src family kinase signaling in vivo.